- Home
- MSW vs CDTX Comparison
MSW vs CDTX Comparison
Compare MSW & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSW
- CDTX
- Stock Information
- Founded
- MSW 2012
- CDTX 2012
- Country
- MSW Hong Kong
- CDTX United States
- Employees
- MSW N/A
- CDTX N/A
- Industry
- MSW
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MSW
- CDTX Health Care
- Exchange
- MSW NYSE
- CDTX Nasdaq
- Market Cap
- MSW 78.0M
- CDTX 242.5M
- IPO Year
- MSW 2024
- CDTX 2015
- Fundamental
- Price
- MSW $6.42
- CDTX $23.22
- Analyst Decision
- MSW
- CDTX Strong Buy
- Analyst Count
- MSW 0
- CDTX 6
- Target Price
- MSW N/A
- CDTX $32.20
- AVG Volume (30 Days)
- MSW 142.4K
- CDTX 60.6K
- Earning Date
- MSW 02-25-2025
- CDTX 11-07-2024
- Dividend Yield
- MSW N/A
- CDTX N/A
- EPS Growth
- MSW N/A
- CDTX N/A
- EPS
- MSW 0.21
- CDTX N/A
- Revenue
- MSW $27,572,692.00
- CDTX $44,653,000.00
- Revenue This Year
- MSW N/A
- CDTX N/A
- Revenue Next Year
- MSW N/A
- CDTX N/A
- P/E Ratio
- MSW $27.71
- CDTX N/A
- Revenue Growth
- MSW 26.09
- CDTX 44.48
- 52 Week Low
- MSW $3.70
- CDTX $10.00
- 52 Week High
- MSW $8.13
- CDTX $24.99
- Technical
- Relative Strength Index (RSI)
- MSW N/A
- CDTX 62.71
- Support Level
- MSW N/A
- CDTX $19.24
- Resistance Level
- MSW N/A
- CDTX $24.31
- Average True Range (ATR)
- MSW 0.00
- CDTX 2.15
- MACD
- MSW 0.00
- CDTX -0.14
- Stochastic Oscillator
- MSW 0.00
- CDTX 73.04
About MSW MING SHING GROUP HOLDINGS LIMITED
Ming Shing Group Holdings Ltd is a holding company, which is primarily operated through its indirectly wholly-owned Hong Kong Operating Subsidiaries, MS (HK) Engineering Limited and MS Engineering Co., Limited. It is engaged in wet trades works, such as plastering works, tile laying works, brick laying works, floor screeding works and marble works. the company is mainly engaged in private-sector projects in Hong Kong. Its private sector projects mainly involve private residential developments and commercial developments. The project owners of its private sector projects are generally property developers, and its customers are generally main contractors and wet trades work subcontractors engaged under such projects.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.